CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Dexmedetomidine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03030911
NCT03030911Phase 4Completed
CompareCT.gov

The Effect of Dexmedetomidine vs Midazolam on Resting Energy Expenditure in Critically Ill Patients: Randomized Controlled Study

Cairo University·interventional·Posted Jan 25, 2017·Updated Mar 27, 2018

In Brief

A Phase 4 clinical trial evaluating Dexmedetomidine, Midazolam, and 2 other interventions for Mechanical Ventilation and 3 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The aim of this study is to compare the effect of dexmedetomidine on resting energy expenditure in relation to the midazolam in critically ill patients using indirect calorimetry

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMechanical Ventilation, Dexmedetomidine, Midazolam, Sedation
CountriesEgypt
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedJan 25, 2017
Enrollment StartJan 1, 2017
Primary CompletionMar 10, 2018
Study CompletionMar 15, 2018
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.4 years ago

Interventions

Dexmedetomidinedrug

The drug will be administered for sedation and its effect on basal metabolic rate will be investigated

Midazolamdrug

The drug will be administered for sedation and its effect on basal metabolic rate will be investigated

Fentanyldrug

The drug will be administered in both groups

Indirect calorimetrydevice

The device will be used for measurement of basal metabolic rate